ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Sumitomo Pharma America, INC.

Official 2024 U.S. DOL Form 5500 summary for Sumitomo Pharma America, INC. (My 401(k) Plan · EIN 22-2536587 · PN 001): $634.07M net assets, 1,141 active participants, and $3.45 per $10,000 (3.45 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorSumitomo Pharma America, INC.
Filing IdentifierMy 401(k) Plan · EIN 22-2536587 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$500M-$1B
Plan Net Assets (2024)$634.07M
Active Participants1,141
Direct Admin Fee Rate$3.45 per $10,000 (3.45 bps)
Cohort Peer Median$6.25 per $10,000 (6.25 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($1,015, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI

Cross-Agency Entity Graph

Related Filings Across Meru Platforms

Verified federal filings reconciled for Sumitomo Pharma America across sibling Meru AI platforms.